Add to Favorites Newsroom RSS Share
New York, NY USA

Our News on Newswise

Increased Breast Cancer Risk Seen in Postmenopausal Women with High Body-Fat Levels Despite Normal BMI

The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer.
9-Feb-2018 12:05 PM EST Add to Favorites

Viviane Tabar, MD, Named Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center

Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for...
5-Dec-2017 3:45 PM EST Add to Favorites

MSK-IMPACT™ Is the First Tumor-Profiling Multiplex Panel Authorized by the FDA, Setting a New Pathway to Market for Future Oncopanels

The US Food and Drug Administration (FDA) announced today the authorization of MSK-IMPACT™ (which stands for integrated mutation profiling of actionable cancer targets), a high throughput, targeted-DNA-sequencing panel for somatic mutations....
15-Nov-2017 1:00 PM EST Add to Favorites

Young Investigators Named Winners of 2017 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in...
9-Nov-2017 9:05 AM EST Add to Favorites

New Study Findings Unlock the Secret of Why Some People with Pancreatic Cancer Live Longer than Others

The pancreatic cancer and immunotherapy experts at Memorial Sloan Kettering Cancer Center (MSK) have shown for the first time why some people with pancreatic cancer live many more years than others with the deadly disease.
7-Nov-2017 1:05 PM EST Add to Favorites

FDA Announces First Approval of Targeted Therapy Based on Basket Study

The US Food and Drug Administration (FDA) has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD). This is the first approval of a targeted therapy based on a basket...
6-Nov-2017 11:05 AM EST Add to Favorites

Norwalk Hospital and Memorial Sloan Kettering Launch Unique Cancer Care Collaboration

Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital, a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing...
16-Oct-2017 6:00 AM EDT Add to Favorites

Cancer Immunologist Andrea Schietinger of Sloan Kettering Institute Honored with Prestigious NIH Director’s New Innovator Award

Cancer immunologist Andrea Schietinger, PhD, of the Sloan Kettering Institute (SKI) at Memorial Sloan Kettering (MSK) has been honored with the prestigious National Institutes of Health (NIH) Director’s New Innovator Award.
5-Oct-2017 10:05 AM EDT Add to Favorites


see all news

Our Experts on Newswise

2-Dec-2014 12:35 PM EST

9-Dec-2013 9:05 AM EST

3-Dec-2013 3:15 PM EST

20-Sep-2013 2:00 PM EDT

12-Mar-2013 6:00 PM EDT

28-Sep-2012 12:40 PM EDT

see all experts

Our YouTube Videos





Chat now!